Patent application number | Description | Published |
20090327288 | CONTENT ENUMERATION TECHNIQUES FOR PORTABLE DEVICES - Arrangements and techniques for enumerating portable device contents via a content management device are discussed herein. The portable device is caused to create and store a first data structure, referred to herein as a portable database, corresponding to the contents of a media library stored thereon. Upon connection to a content management device, the portable database is copied to the content management device, and is used in conjunction with information stored by the content management device in a second data structure, referred to herein as a device content table, to efficiently enumerate and provide other manipulation of the contents of the media library stored on the portable device. | 12-31-2009 |
20120203796 | MEDIA CONTENT LOCATION AWARENESS AND DECISION MAKING - Various embodiments related to the ability to find content for consumption across all endpoint computing devices in a computing system are disclosed. For example, one disclosed embodiment provides a method for presenting content including aggregating endpoint metadata for each endpoint computing device in a computing system and content metadata of content stored on each of a plurality of endpoint computing devices, receiving a request for a content item on a selected endpoint computing device, querying aggregated endpoint metadata and content metadata to find instances of the content item and corresponding endpoint computing device locations, generating a ranked list of instances of the content item based on selection criteria, and selecting an instance of the content item from the ranked list for playback by the selected endpoint computing device. | 08-09-2012 |
20120203932 | MULTI-MASTER MEDIA METADATA SYNCHRONIZATION - Various embodiments related to the ability to expose content for synchronization and consumption across all endpoint computing devices in a computing system are disclosed. For example, one disclosed embodiment provides a method for communicating between authenticated clients of a cloud-based computing system, including sending a read request for metadata of each of a plurality of endpoint computing devices and content stored on each of the plurality of endpoint computing devices that is aggregated in a data store, receiving the requested metadata. The method further includes performing a content consumption operation that changes a state of the requested metadata. The method further includes sending updated metadata generated based on the content consumption operation to synchronize aggregated metadata in the data store, and deleting local metadata. | 08-09-2012 |
Patent application number | Description | Published |
20090060866 | PHOSPHADIAZINE HCV POLYMERASE INHIBITORS I AND II - Provided herein are phosphadiazine polymerase inhibitor, for example, of any of Formula I, II, III, I′, II′, I″, II″, Ia, IIa, or IIIa, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof. | 03-05-2009 |
20110150827 | 5,5-FUSED ARYLENE OR HETEROARYLENE HEPATITIS C VIRUS INHIBITORS - Provided herein are 5,5-fused heteroarylene hepatitis C virus inhibitor compounds, for example, of Formula I, IA, or IB, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof. | 06-23-2011 |
20120252721 | METHODS FOR TREATING DRUG-RESISTANT HEPATITIS C VIRUS INFECTION WITH A 5,5-FUSED ARYLENE OR HETEROARYLENE HEPATITIS C VIRUS INHIBITOR - Provided herein are methods for treating or preventing drug-resistant hepatitis C virus infection in a subject, which comprises administering to the subject a 5,5-fused heteroarylene hepatitis C virus inhibitor compound, for example, of Formula I, IA, or IB. | 10-04-2012 |
20130071352 | 5,5-FUSED ARYLENE OR HETEROARYLENE HEPATITIS C VIRUS INHIBITORS - Provided herein are 5,5-fused heteroarylene hepatitis C virus inhibitor compounds, for example, of Formula I, IA, or IB, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof. | 03-21-2013 |
Patent application number | Description | Published |
20110015366 | NOVEL CHAIN EXTENDERS FOR POLYURETHANE ELASTOMER FORMULATIONS - A composition that includes: a compound of the formula (I) in which R | 01-20-2011 |
20110076245 | NOVEL INVERSE LATICES THAT ARE FREE OF OXYETHYLENE DERIVATIVES, AND COSMETIC, DERMOCOSMETIC, DERMOPHARMACEUTICAL OR PHARMACEUTICAL COMPOSITIONS COMPRISING SAME - Novel inverse latices comprising, as inverting agents, at least one compound of formula (I): R | 03-31-2011 |
20130053452 | COMPOSITION MADE OF POLYALKOXYLATED DERIVATIVES OF TRIMETHYLOLPROPANE AND FATTY ALCOHOLS, METHOD FOR PREPARING SAID COMPOSITION, AND USE THEREOF AS A REVERSER IN SELF-REVERSIBLE REVERSE LATEXES - A novel composition made of polyalkoxylated derivatives of trimethylolpropane and fatty alcohols, the composition lending itself to the preparation thereof and to the use thereof as a reversing agent for a reversible reverse latex. | 02-28-2013 |
20140213705 | COMPOSITION MADE OF POLYALKOXYLATED DERIVATIVES OF TRIMETHYLOLPROPANE AND FATTY ALCOHOLS, METHOD FOR PREPARING SAID COMPOSITION, AND USE THEREOF AS A REVERSER IN SELF-REVERSIBLE REVERSE LATEXES - The invention relates to a novel composition made of polyalkoxylated derivatives of trimethylolpropane and fatty alcohols, said composition lending itself to the preparation thereof and to the use thereof as a reversing agent for a reversible reverse latex. | 07-31-2014 |
20140357735 | COMPOSITION MADE OF POLYALKOXYLATED DERIVATIVES OF TRIMETHYLOLPROPANE AND FATTY ALCOHOLS, METHOD FOR PREPARING SAID COMPOSITION, AND USE THEREOF AS A REVERSER IN SELF-REVERSIBLE REVERSE LATEXES - The invention relates to a novel composition made of polyalkoxylated derivatives of trimethylolpropane and fatty alcohols, said composition lending itself to the preparation thereof and to the use thereof as a reversing agent for a reversible reverse latex. | 12-04-2014 |
Patent application number | Description | Published |
20080223627 | Synchronization of haptic effect data in a media transport stream - Haptic information in a series of frames of a media transport stream is identified and time stamps corresponding thereto are determined in accordance with a master time code signal embedded in the media transport stream. Each media transport stream frame containing haptic information is subsequently assigned a time stamp so that it will be used to activate an actuator at a proper time responsive to the time stamp to generate a haptic effect in accordance with the haptic information. | 09-18-2008 |
20090322496 | Providing Haptic Feedback On A Touch Surface - Systems and methods for providing haptic feedback to a touch surface are described herein. In one embodiment, among many, a layered structure comprises a first conducting layer electrically coupled to a first terminal of a power source and a second conducting layer electrically coupled to a second terminal of the power source. The layered structure also comprises a spacing layer electrically isolating the first conducting layer from the second conducting layer. Also, an actuation layer is positioned between the first conducting layer and the second conducting layer. The actuation layer includes a material that reacts to an electrical stimulus. | 12-31-2009 |
20100287311 | SYSTEM AND METHOD FOR ORDERING HAPTIC EFFECTS - A signal associated with multiple haptic effects is received, each haptic effect from the multiple haptic effects being associated with a time slot from multiple time slots. Each haptic effect from the multiple haptic effects is associated with an effect slot from multiple effect slots at least partially based on the time slot associated with that haptic effect. An output signal is sent for each effect slot from the multiple effect slots, when the associated haptic effect is scheduled for its time slot. | 11-11-2010 |
20110109423 | Systems and Methods for Minimal Haptic Implementation - Systems and methods for minimal haptic implementation are disclosed. For example, one disclosed system includes: an actuator; and a control-circuit in communication with the actuator, the control circuit configured to: receive a 2-bit signal including a first bit indicating a power state and a second bit indicating an actuation state; and transmit a power signal based on the two bit signal, the power signal configured to cause the actuator to operate at the actuation state at a fixed power. | 05-12-2011 |
20120249464 | SYSTEM AND METHOD FOR ORDERING HAPTIC EFFECTS - A signal associated with multiple haptic effects is received, each haptic effect from the multiple haptic effects being associated with a time slot from multiple time slots. Each haptic effect from the multiple haptic effects is associated with an effect slot from multiple effect slots at least partially based on the time slot associated with that haptic effect. An output signal is sent for each effect slot from the multiple effect slots, when the associated haptic effect is scheduled for its time slot. | 10-04-2012 |
20140068110 | SYSTEM AND METHOD FOR ORDERING HAPTIC EFFECTS - A signal associated with multiple haptic effects is received, each haptic effect from the multiple haptic effects being associated with a time slot from multiple time slots. Each haptic effect from the multiple haptic effects is associated with an effect slot from multiple effect slots at least partially based on the time slot associated with that haptic effect. An output signal is sent for each effect slot from the multiple effect slots, when the associated haptic effect is scheduled for its time slot. | 03-06-2014 |
20150058722 | SYSTEM AND METHOD FOR ORDERING HAPTIC EFFECTS - A signal associated with multiple haptic effects is received, each haptic effect from the multiple haptic effects being associated with a time slot from multiple time slots. Each haptic effect from the multiple haptic effects is associated with an effect slot from multiple effect slots at least partially based on the time slot associated with that haptic effect. An output signal is sent for each effect slot from the multiple effect slots, when the associated haptic effect is scheduled for its time slot. | 02-26-2015 |
Patent application number | Description | Published |
20130265286 | SOUND TO HAPTIC EFFECT CONVERSION SYSTEM USING MULTIPLE ACTUATORS - A haptic conversion system is provided that analyzes an audio signal, generates a plurality of haptic signals based on the analysis of the audio signal, and plays the generated plurality of haptic signals through a plurality of actuators to produce one or more haptic effects. The haptic conversion system maps the generated plurality of haptic signals to the plurality of actuators based on one or more audio characteristics of the audio signal. Each generated haptic signal includes one or more haptic parameters, and is played at its mapped actuator to generate the one or more haptic effects. | 10-10-2013 |
20140125467 | ENCODING DYNAMIC HAPTIC EFFECTS - A system is provided that encodes one or more dynamic haptic effects. The system defines a dynamic haptic effect as including a plurality of key frames, where each key frame includes an interpolant value and a corresponding haptic effect. An interpolant value is a value that specifies where an interpolation occurs. The system generates a haptic effect file, and stores the dynamic haptic effect within the haptic effect file. | 05-08-2014 |
20140160034 | ENHANCED DYNAMIC HAPTIC EFFECTS - A system is provided that generates a dynamic haptic effect that includes one or more key frames, where each key frame includes a first interpolant value and a first haptic effect. The system further receives an interpolant value, where the interpolant value is between at least two interpolant values of at least two key frames. The system further determines the dynamic haptic effect from the interpolant value. The system further distributes the dynamic haptic effect among a plurality of actuators. | 06-12-2014 |
20140167941 | HAPTIC SYSTEM WITH INCREASED LRA BANDWIDTH - A method of generating a haptic effect on a linear resonance actuator (“LRA”) having a resonant frequency includes receiving a haptic effect signal for the haptic effect, where the haptic effect comprises a desired frequency that is off-resonant from the LRA. The method further includes generating a first sine wave at the desired frequency and generating a second sine wave at or near the resonant frequency. The method further includes combining the first sine wave and the second sine wave to generate a drive signal. | 06-19-2014 |
20140267069 | Systems and Methods For Syncing Haptic Feedback Calls - Systems and methods for syncing haptic feedback calls are disclosed. For example, one described method includes: receiving an input signal associated with a user interface event; determining a haptic feedback signal based at least in part on the input signal; and determining whether or not to output the haptic feedback signal to haptic output device based at least in part on a haptic feedback rate. | 09-18-2014 |
20150097657 | GENERATING HAPTIC EFFECTS WHILE MINIMIZING CASCADING - A system that generates haptic effects using an actuator receives a haptic effect definition that defines a haptic effect. The system pre-processes the haptic effect definition by determining if the actuator is capable of playing the haptic effect. The system then post-processes the haptic effect definition by adjusting a force value based on an estimate or measurement of a state of the actuator during a playing of the haptic effect. | 04-09-2015 |
20150102918 | ENCODING DYNAMIC HAPTIC EFFECTS - A system is provided that encodes one or more dynamic haptic effects. The system defines a dynamic haptic effect as including a plurality of key frames, where each key frame includes an interpolant value and a corresponding haptic effect. An interpolant value is a value that specifies where an interpolation occurs. The system generates a haptic effect file, and stores the dynamic haptic effect within the haptic effect file. | 04-16-2015 |
20150130706 | HAPTIC TRIGGER CONTROL SYSTEM - A system that controls a haptic effect experienced at a trigger is provided. The system receives a haptic effect definition including haptic data. The system further receives trigger data including at least one of: a position of a trigger of a peripheral device; or a range of the trigger of the peripheral device. The system further determines whether a trigger condition is reached based on the received trigger data. The system further sends a haptic instruction and the haptic effect definition to the peripheral device when the trigger condition is reached. The system further causes a haptic output device (or multiple haptic output devices) to produce haptic effects that are based on the haptic effect definition at the peripheral device in response to the haptic instruction. | 05-14-2015 |
20150130707 | HAPTIC SPATIALIZATION SYSTEM - A system is provided that controls a haptic effect experienced at a peripheral device. The system receives a haptic effect definition including haptic data. The system further receives spatialization data including: a distance of the haptic effect; a direction of the haptic effect; or a flow of the haptic effect. The system further includes modifying the haptic effect definition based on the received spatialization data. The system further includes sending a haptic instruction and the modified haptic effect definition to the peripheral device. The system further includes causing one or more haptic output devices to produce one or more haptic effects based on the modified haptic effect definition at the peripheral device in response to the haptic instruction. | 05-14-2015 |
20150145656 | METHOD AND APPARATUS OF BODY-MEDIATED DIGITAL CONTENT TRANSFER AND HAPTIC FEEDBACK - The disclosure relates to systems and methods of transferring/storing digital content, and/or providing haptic feedback via wearable devices directly or indirectly responsive to an event such as a communication, an event occurring in an electronic environment and/or physical environment, the transfer of digital content, and/or other events. Wearable devices may be worn at various locations on a body of the user. Each location may be associated with a wearable device. Different haptic feedback may be provided at different locations based on the event such that the events may be distinguished or otherwise identified based on the location at which haptic feedback is provided. The locations may be stored in a configuration of wearable devices that act as a mapping of the wearable devices. The locations and/or haptic feedback itself may be varied based on the context and/or properties such as size of digital content or status of the transfer. | 05-28-2015 |
Patent application number | Description | Published |
20100143251 | COMPOUNDS AND AMYLOID PROBES THEREOF FOR THERAPEUTIC AND IMAGING USES - The present invention provides compounds and amyloid probes thereof that allow for an antemortem method of diagnosing AD and quantitating the extent or progression of amyloid deposits (plaques) by in vivo imaging of amyloid and/or amyloid deposits in the regions of the brain. Preferably, an amyloid probe of the invention can cross the blood-brain barrier and distinguish AD brain from normal brain. An amyloid probe can be administered to a patient in amounts suitable for in vivo imaging of amyloid deposits. Amyloid probes of the invention can also be used to detect and quantitate amyloid deposits in diseases including, without limitation, Down's syndrome, familial AD and homozygotes for the apolipoprotein E4 allele. In one aspect, the compounds may be used in the treatment or prophylaxis of diseases that include, without limitation, AD and type 2 diabetes mellitus. The compounds and amyloid probes of the invention include analogs, salts, pharmaceutical compositions, derivatives, prodrugs, racemic mixtures or tautomeric forms thereof. | 06-10-2010 |
20100143253 | COMPOUNDS AND AMYLOID PROBES THEREOF FOR THERAPEUTIC AND IMAGING USES - The present invention provides compounds and amyloid probes thereof that allow for an antemortem method of diagnosing AD and quantitating the extent or progression of amyloid deposits (plaques) by in vivo imaging of amyloid and/or amyloid deposits in the regions of the brain. Preferably, an amyloid probe of the invention can cross the blood-brain barrier and distinguish AD brain from normal brain. An amyloid probe can be administered to a patient in amounts suitable for in vivo imaging of amyloid deposits. Amyloid probes of the invention can also be used to detect and quantitate amyloid deposits in diseases including, without limitation, Down's syndrome, familial AD and homozygotes for the apolipoprotein E4 allele. In one aspect, the compounds may be used in the treatment or prophylaxis of diseases that include, without limitation, AD and type 2 diabetes mellitus. The compounds and amyloid probes of the invention include analogs, salts, pharmaceutical compositions, derivatives, prodrugs, racemic mixtures or tautomeric forms thereof. | 06-10-2010 |
20100150833 | COMPOUNDS AND AMYLOID PROBES THEREOF FOR THERAPEUTIC AND IMAGING USES - The present invention provides compounds and amyloid probes thereof that allow for an antemortem method of diagnosing AD and quantitating the extent or progression of amyloid deposits (plaques) by in vivo imaging of amyloid and/or amyloid deposits in the regions of the brain. Preferably, an amyloid probe of the invention can cross the blood-brain barrier and distinguish AD brain from normal brain. An amyloid probe can be administered to a patient in amounts suitable for in vivo imaging of amyloid deposits. Amyloid probes of the invention can also be used to detect and quantitate amyloid deposits in diseases including, without limitation, Down's syndrome, familial AD and homozygotes for the apolipoprotein E4 allele. In one aspect, the compounds may be used in the treatment or prophylaxis of diseases that include, without limitation, AD and type 2 diabetes mellitus. The compounds and amyloid probes of the invention include analogs, salts, pharmaceutical compositions, derivatives, prodrugs, racemic mixtures or tautomeric forms thereof. | 06-17-2010 |